Skip to main content

Webinar: Revealing Parkinson's Disease and Traumatic Brain Injury Biomarkers with Simple Western

Webinar Summary

The brain is a complex organ. As you can imagine, studying it is not a trivial task particularly when looking at Parkinson's Disease or traumatic brain injury. Western blot has been traditionally used to study protein changes. However, it has limitations such as labor-intensive workflows and poor quality data. To get a comprehensive understanding of how proteins play a role in complex physiological events, these researchers have been using Simple Western, a complete reinvention of the old-school Western blot that is gel-free, blot-free, and hands-free. Simple Western™ offers highly reproducible and quantitative data in an automated platform, and it delivers fully analyzed data in a matter of hours.

In this webinar, you will learn:

  • The role of Parkinson's disease associated mutation p.D620N and other point mutations affecting VPS35 a protein linked to late onset autosomal dominant Parkinsonism
  • The changes in protein levels that take place during the dismantling and reorganization phases after traumatic brain injury. In particular ARC, I-Kappa beta and phosphorylated I-Kappa beta, Multidrug resistance protein (MRP)
  • How Simple Western is helping researchers drastically improve throughput, save time and sample and increase sensitivity in comparison with traditional Western blotting techniques


Lise Munsie, Ph.D., Postdoctoral Research Fellow Centre for Applied Neurogenetics, Medical Genetics. Univ. British Columbia

Ryan Hart, M.S., Barrow Neurological Institute at Phoenix Children's Hospital

Dan Griffiths, B.S., Barrow Neurological Institute at Phoenix Children's Hospital